Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Chickenpox01:20

Chickenpox

Chickenpox is an acute, highly contagious disease caused by the varicella-zoster virus (VZV), a double-stranded DNA virus belonging to the Herpesviridae family. Its transmission occurs primarily through the inhalation of respiratory droplets or direct contact with vesicular fluid from skin lesions. The incubation period typically ranges from 10 to 21 days, during which the virus replicates and disseminates through sequential phases within the host. Although generally self-limiting in children,...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Vaccinations01:51

Vaccinations

Overview
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Cell type-dependent induction of type I interferon and PARP1 activation in astrocytes and neurons during chikungunya virus infection.

Microbiology spectrum·2026
Same author

Single-cell profiling of immune activation, dysregulation, and reconstitution in rhesus macaques after measles virus infection.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same author

IRF7 deficiency in myeloid cells results in increased disease severity and death during alphavirus encephalomyelitis despite intact expression of type I interferons.

Journal of neuroinflammation·2026
Same author

Distinct Humoral Response Development to Measles Virus across Vaccine Platforms.

The Journal of infectious diseases·2026
Same author

Neurotropic alphavirus infection induces PARP-1 hyperactivation-mediated energy collapse in motor neurons.

Journal of virology·2026
Same author

Interferon-β Modulates Early Viral Replication Kinetics and Innate Responses to Non-Fatal Alphavirus Encephalomyelitis.

Pathogens (Basel, Switzerland)·2026
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
Ver todos los artículos relacionados

Video Experimental Relacionado

Updated: May 30, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

El sarampión es el sarampión.

William J Moss1, Diane E Griffin

  • 1Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA. wmoss@jhsph.edu

Lancet (London, England)
|August 23, 2011
PubMed
Resumen
Este resumen es generado por máquina.

La vacunación contra el sarampión redujo significativamente las muertes, pero la disminución de la inmunidad y las brechas de cobertura corren el riesgo de un resurgimiento. Mantener altas tasas de vacunación es crucial para el control del sarampión y los esfuerzos de erradicación.

Más Videos Relacionados

Myelin Oligodendrocyte Glycoprotein (MOG35-55) Induced Experimental Autoimmune Encephalomyelitis (EAE) in C57BL/6 Mice
08:03

Myelin Oligodendrocyte Glycoprotein (MOG35-55) Induced Experimental Autoimmune Encephalomyelitis (EAE) in C57BL/6 Mice

Published on: April 15, 2014

Videos de Experimentos Relacionados

Last Updated: May 30, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Myelin Oligodendrocyte Glycoprotein (MOG35-55) Induced Experimental Autoimmune Encephalomyelitis (EAE) in C57BL/6 Mice
08:03

Myelin Oligodendrocyte Glycoprotein (MOG35-55) Induced Experimental Autoimmune Encephalomyelitis (EAE) in C57BL/6 Mice

Published on: April 15, 2014

Área de la Ciencia:

  • Epidemiología La epidemiología.
  • Salud Pública La salud pública.
  • Virología Virología.

Sus antecedentes:

  • El sarampión, una enfermedad viral altamente contagiosa, históricamente causó millones de muertes anuales en todo el mundo.
  • La vacunación contra el sarampión ha reducido dramáticamente la mortalidad, con 164.000 muertes en 2008, destacando su importancia para la salud pública.

Objetivo del estudio:

  • Para enfatizar el papel crítico de la vacunación contra el sarampión en la salud pública.
  • Para resaltar la amenaza que representa la disminución de la cobertura de vacunación para el progreso en el control del sarampión.
  • Identificar los desafíos que obstaculizan el control y la erradicación continuos del sarampión.

Principales métodos:

  • Este estudio es una revisión y análisis de los datos existentes sobre la incidencia del sarampión, la mortalidad y la cobertura de vacunación.
  • Sintetiza información sobre brotes recientes de sarampión y sus factores contribuyentes.
  • Se discuten los desafíos logísticos, financieros y políticos para el control del sarampión.

Principales resultados:

  • La vacunación contra el sarampión ha llevado a reducciones notables en las muertes relacionadas con el sarampión a nivel mundial.
  • Los brotes recientes en varias regiones demuestran la rápida reaparición del sarampión cuando la inmunidad de la población no se mantiene.
  • Mantener una alta inmunidad de la población es esencial para evitar que el virus del sarampión vuelva a entrar en las comunidades.

Conclusiones:

  • El control continuo del sarampión y la eventual erradicación dependen de la superación de los desafíos logísticos, financieros y de la voluntad política.
  • Mantener una alta cobertura de vacunación contra el sarampión es fundamental para proteger a las generaciones futuras de esta devastadora enfermedad.